Now in its 10th year, the Annual Biotech in Europe Investor Forum is an exclusive and highly transactional forum for investing and partnering in the Biotech and Pharma industry. The two-day conference programme will give you access to some of the leading players in the industry and will provide you with truly excellent networking opportunities as it boasts an online partnering system with 500 meeting slots available for all attendees to book before the event. With over 70 presenting companies and exciting plenary panel sessions from experts in their sector, the forum will provide a great opportunity to gain insight into partnering and investment trends in the Biotech and Pharma industry. We anticipate up to 400 delegates, and 150 companies are registered so far.

The partnering sessions feature presentations by representatives of the leading pharmaceutical and speciality pharmaceutical companies in the world. This includes; Bristol Myers Squibb, Merck, Merck Serono, Novartis, Novo Nordisk, Nycomed, Pfizer, and Roche.

The Program features:
Public Market & Pharma M+A Panel
   chaired by Stephanie Léouzon, Senior Director, Credit Suisse
Investment Panel
   chaired by Genghis Lloyd-Harris, Partner, Abingworth Management Ltd
Partnering Panel
   chaired by Dr Fintan Walton, CEO, PharmaVentures
Corporate Venture Panel
   chaired by Roel Bulthuis, Head, Merck Serono Ventures
CNS and Neurology Panel
   chaired by Lubor Gaal, Executive Director, Strategic Transactions, Bristol Myers Squibb
Medtech Investment Panel
   chaired by Markus Hosang, General Partner, Biomed Ventures AG
Platform Technologies and Novel Therapeutics Panel
   chaired by Fintan Walton, Chief Executive Officer, PharmaVentures Ltd
Oncology Investment Panel
   chair to be confirmed.
500 meeting slots with the online 1–2–1 meeting system
Evening Networking Reception and two networking lunches
2010 Awards by PharmaVentures. The award recognises the major investment and partnering deals in the industry.

Confirmed Speakers Include:
Addex Pharmaceuticals, Vincent Mutel, CEO
Affimed Therapeutics AG, Florian Fisher, CFO
Alta Partners, Ekaterina Smirnyagina, Venture Partner
Antisoma Research, Nicholas Adams, Vice President, Business Development
Astex Therapeutics, Harren Jhoti, CEO
Æterna Zentaris Inc., Professor Juergen Engel, President & CEO
Atlas Venture, Regina Hodits, Partner
Bayer Schering Pharma AG, Nils Peter Debus, Senior Director, Global Business Development & Licensing
Bellvue Asset Management LLC, Eric Bernhardt, Head of Healthcare Team
Biocartis, Rudi Pauwels, CEO
Biocompatibles International, Crispin Simon, CEO
Boehringer Ingelheim, Ilka Wicke, Investment Manager
Bristol Myers Squibb, Lubor Gaal, Executive Director, Strategic Transactions
Clovis Oncology, Inc., Patrick J. Mahaffy, President & CEO
Deloitte LLP, Chris Britten, Head, Corporate Finance, Healthcare & Life Sciences
Dicerna Pharmaceuticals, Inc. Martin D. Williams, Senior Vice President, Chief Business Officer
Egalet, Jakob Knudsen, Chief Commercial Officer
Equity Development Ltd, Lorenza Castellón, Health & Biotech Equity Analyst
Forbion Capital Partners, Christina Takke, Principal
GILDE Healthcare Partners, Arthur Franken, Partner
F. Hoffmann-La Roche Ltd, Andrew Jefferson, Global Licensing Director
Merck & Co. Inc., Margaret Beer, Senior Director, Scientific Liaison, Licensing and External Research, Europe
Molecular Partners AG, Christian Zahnd, CEO
Movetis, Catherine Moukheibir, CFO
NeurAxon Inc., Lawrence Bloch, CEO
Novartis Pharmaceuticals, Esteban Pombo-Villar, Head of Strategic Alliance Management EU
Novartis Venture Fund, Dr. Reinhard J. Ambros, Executive Director and Global Head
Nycomed, Carlos de Sousa, VP Corporate Licensing, Business Development
Pfizer, Inc., Alex Chanas, Senior Director, Worldwide Licensing and Business Development
Roche Partnering, Hans Christinger, Global Licensing Director
Roche Venture Fund, Carole Nuechterlein, Head of Roche Venture Fund
Scancell, Richard Goodfellow, Executive Commercial Director
Sunstone Capital, Sten Verland, Partner
Syndax Pharmaceuticals, Inc., Joanna Horobin, President & CEO
Syntaxin, Melanie Lee, Chief Executive Officer
Takeda Research Investment Inc., Graeme Martin, President & CEO

We have limited discounted presenting and exhibiting places available and those applications received first are given prior consideration.

For more information please take a look at last year’s event at: Biotech In Europe Investor Forum 2009.

Presenting Opportunities

Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business.

Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.

The 2009 event was fully sold out – don’t miss out on your opportunity to join us in Zurich and showcase your company to an audience of investors, money managers, VC’s and fund managers. Click here to see the list of 09 presenters >>>

The forum is recognised as the leading international stage for those interested in investing in the biotech and life science industry and is highly transactional, drawing together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners.

Sponsorship:

Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market.

Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.

To learn more about sponsorship & presenting opportunities, please contact Zoe Harris+ 44 20 7405 5579 or by email

* to be confirmed